CIP2A is a prime synthetic-lethal target for BRCA-mutated cancers

Salomé Adam(Mount Sinai Hospital), Daniel Durocher(University of Toronto)
bioRxiv (Cold Spring Harbor Laboratory)
February 8, 2021
Cited by 17


Related Papers